Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Landos Biopharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 31 | 23 | −8 |
| Shares | 21.6M | 15.7M | −5.86M (−27.1%) |
| Value | $14.0M | $7.87M | −$6.17M (−43.9%) |
New holders (4)
Institutions that held Landos Biopharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 52,564 | $26.0K | 0.00% |
| Susquehanna International Group, LLP | 21,064 | $10.5K | 0.00% |
| Jane Street Group, LLC | 14,826 | $7.41K | 0.00% |
| UBS Group AG | 375 | $188 | 0.00% |
Sold out (12)
Institutions that held Landos Biopharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| RTW Investments, LP | 3,975,722 | $2.58M |
| OUP Management Co., LLC | 1,237,667 | $804.0K |
| Botty Investors LLC | 127,262 | $83.0K |
| Two Sigma Investments, LP | 19,420 | $13.0K |
| Two Sigma Advisers, LP | 19,800 | $13.0K |
| Bank of America Corp | 16,482 | $11.0K |
| Balyasny Asset Management LLC | 15,687 | $10.0K |
| Goldman Sachs Group Inc | 13,092 | $9.00K |
| Man Group plc | 14,387 | $9.00K |
| Stratos Wealth Partners, LTD. | 10,000 | $7.00K |
| BNP Paribas Arbitrage, SA | 1,122 | $729 |
| China Universal Asset Management Co., Ltd. | 377 | $0 |